Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline M Moore

Showing results (201-210 of 232) with videos related to

Pageof 24
Sort By:
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
European Urology|October 5, 2014
Focal therapy: patients, interventions, and outcomes--a report from a consensus meetingIan A Donaldson, Roberto Alonzi, Dean Barratt, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
Implementation Science : IS|November 26, 2016
Reorganising specialist cancer surgery for the twenty-first century: a mixed methods evaluation (RESPECT-21)Naomi J Fulop, Angus I G Ramsay, Cecilia Vindrola-Padros, et al.
European Urology|December 12, 2018
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk StratificationSami Hamid, Ian A Donaldson, Yipeng Hu, et al.
European Urology|May 24, 2020
Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysisNiranjan J Sathianathen, Altan Omer, Eli Harriss, et al.
BJUI Compass|October 21, 2022
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testingEoin Dinneen, Gregory L Shaw, Roseann Kealy, et al.
European Urology|June 29, 2016
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task ForceCaroline M Moore, Francesco Giganti, Peter Albertsen, et al.
Journal of Medical Economics|September 1, 2023
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysisDeepika Reddy, Marieke van Son, Max Peters, et al.
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
Pageof 24

Showing results (201-210 of 232) with videos related to

Sort By:
Pageof 24
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
European Urology|October 5, 2014
Focal therapy: patients, interventions, and outcomes--a report from a consensus meetingIan A Donaldson, Roberto Alonzi, Dean Barratt, et al.
The Journal of Urology|November 23, 2016
The Effect of Dutasteride on Magnetic Resonance Imaging Defined Prostate Cancer: MAPPED-A Randomized, Placebo Controlled, Double-Blind Clinical TrialCaroline M Moore, Nicola L Robertson, Fatima Jichi, et al.
Implementation Science : IS|November 26, 2016
Reorganising specialist cancer surgery for the twenty-first century: a mixed methods evaluation (RESPECT-21)Naomi J Fulop, Angus I G Ramsay, Cecilia Vindrola-Padros, et al.
European Urology|December 12, 2018
The SmartTarget Biopsy Trial: A Prospective, Within-person Randomised, Blinded Trial Comparing the Accuracy of Visual-registration and Magnetic Resonance Imaging/Ultrasound Image-fusion Targeted Biopsies for Prostate Cancer Risk StratificationSami Hamid, Ian A Donaldson, Yipeng Hu, et al.
European Urology|May 24, 2020
Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysisNiranjan J Sathianathen, Altan Omer, Eli Harriss, et al.
BJUI Compass|October 21, 2022
Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testingEoin Dinneen, Gregory L Shaw, Roseann Kealy, et al.
European Urology|June 29, 2016
Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task ForceCaroline M Moore, Francesco Giganti, Peter Albertsen, et al.
Journal of Medical Economics|September 1, 2023
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysisDeepika Reddy, Marieke van Son, Max Peters, et al.
The Journal of Urology|April 4, 2023
Evaluation of Outcomes Following Focal Ablative Therapy for Treatment of Localized Clinically Significant Prostate Cancer in Patients >70 Years: A Multi-institute, Multi-energy 15-Year ExperienceDavid Habashy, Deepika Reddy, Max Peters, et al.
Pageof 24